News
Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance ...
Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...
A new AI model accurately detected cardiac amyloidosis from echocardiograms with higher accuracy vs. other amyloidosis risk ...
An artificial intelligence (AI) model developed by Mayo Clinic and Ultromics, Ltd., an AI echocardiography company based in ...
The AI model uses a single echocardiography videoclip to differentiate cardiac amyloidosis from other similar heart ...
An artificial intelligence (AI) model developed by Mayo Clinic and Ultromics, Ltd., an AI echocardiography company based in ...
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced it plans to offer laboratory testing based on the ...
GE HealthCare Technologies Inc. (NASDAQ: GEHC) is one of the best up and coming stocks to invest in now. On June 24, On June ...
Helicobacter pylori, best known for causing stomach ulcers, was shown to block the build-up of both amyloid-beta and tau in our study.
Read about a CAR T cell therapy that appears effective against light chain (AL) amyloidosis.
Researchers developed trehalose-functionalized peptide amphiphiles (TPAs) that self-assemble into supramolecular nanostructures and demonstrated these TPAs can inhibit amyloid beta aggregation. In ...
Learn how to navigate your diagnosis of hereditary transthyretin amyloidosis (hATTR) with polyneuropathy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results